Publishing Team Leader, Scientific Reports

Req ID:  45934

Tranent, ELN, GB

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary


Working as a Publishing Team Leader,Scientific Reports you’ll lead a team which provides support to study management in the publishing of study reports.

We are seeking a Publishing Team Leader, Scientific Reports for our Report Centre site located Tranent.


The following are responsibilities related to the Publishing Team Leader, Scientific Reports:

•    Manage team to compile and publish study reports to current industry standards.
•    Ensure client specific requirements are fully met 
•    Perform quality check of reports and regulatory documents
•    Use variety of software for production of regulatory reports 
•    Manage the scheduling of the workload within the team
•    Improve publication processes to contribute to the ontime delivery of submission ready study reports
•    Create and maintain control of report templates
•    Work collaboratively with a variety of personnel who contribute to the scientific content of the study report

The following are minimum requirements related to the Publishing Team Leader, Scientific Reports position:

•    Business Administration or other relevant Publishing qualification
•    Extensive experience with document management technologies or journal production
•    Experience with electronic publishing software
•    Proven experience of leading a team with good leadership skills
•    Excellent skills in Word, Excel and Adobe
•    Proven ability of working within a pressured environment and to tight deadlines

Starting Salary for this position is £30,000.

The closing date for applications is 29 January 2020.

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.


About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 14,000 employees within 80 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2018, revenue increased by 22% to $2.27 billion from $1.86 billion in 2017.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2018.